A Scalable Platform for Biomarker-Led Insight

From a Single Assay to a Biomarker Platform

FAST>ER™ represents the first clinical application of a broader biomarker platform designed to support objective molecular insight across multiple clinical contexts.

The platform approach enables disciplined expansion into additional applications where biomarker signals may provide meaningful context, guided by scientific evidence and biological relevance.

In a modern lab, a technician diligently examines samples through a microscope, demonstrating professionalism and scientific inquiry, amidst advanced lab apparatus.
A mid-adult Caucasian woman and a mixed race man, both clad in lab coats, engage intently over research data in a bright laboratory setting.

Platform Philosophy

The biomarker platform is built around a core set of principles:

  • Biological relevance first
  • Evidence-driven expansion
  • Reuse of validated assay architecture
  • Clear separation between clinical use and exploratory research

Each application is evaluated independently to ensure scientific integrity and appropriate interpretation.

High-tech lab with professionals analyzing biological samples under microscopes for medical testing and development. Scientists in lab coats conducting tests with microscopes. Concept of medicine innovation, clinical trials, and healthcare research.

Core Platform Components

The platform integrates several foundational elements:

  • Biomarker targets selected for biological relevance
  • Immunoassay architecture optimized for point-of-care use
  • Analytical tools to support interpretation
  • Workflow-compatible formats adaptable across settings

This modular structure supports consistency while allowing application-specific refinement.

Couple of chemists working at the lab in a chemical plant and mixing products in test tubes

Initial Application Focus

The platform’s initial focus centers on time-critical care environments, where early molecular insight may complement existing clinical assessment tools.

Current areas of focus include:

  • Acute neurologic injury
  • Ischemic injury
  • High-acuity clinical decision settings

These contexts emphasize speed, objectivity, and integration into established workflows.

Female researcher wearing lab coat and gloves examining specimen for scientific discovery

Expanding the Platform

Beyond initial applications, the platform supports exploration of additional clinical and translational areas where biomarker information may be relevant.

Areas under evaluation include:

  • Neurodegeneration and chronic injury
  • Oncology-related stratification and monitoring
  • Neonatal and perinatal injury
  • Veterinary and animal health applications

Each area is explored incrementally, guided by biological rationale and supporting data.

Two veterinarians wearing scrubs assist a small dog on a table at a veterinary clinic, consulting a digital tablet for treatment details during the afternoon.

Veterinary & Animal Health

The platform architecture is adaptable to non-human applications, including animal health contexts where rapid, on-site biomarker assessment may be valuable.

Potential areas include:

  • Disease monitoring
  • Injury-related biomarker assessment
  • Field-deployable testing environments

Animal health applications are developed independently and tailored to their specific use environments.

Scientist analyze biochemical samples in advanced scientific laboratory. Medical professional use microscope look microbiological developmental of viral. Biotechnology research in science lab.

A Disciplined Path to Expansion

Platform expansion follows a structured scientific process:

  • Biological relevance and rationale
  • Feasibility within the assay architecture
  • Analytical evaluation
  • Clinical or translational study
  • Evidence-based refinement

This approach ensures that growth of the platform remains grounded in data and scientific responsibility.

Close-up of a gloved hand inserting a blood sample tube into an automated medical analyzer in a clinical lab. The image conveys precision, sterile technique, and advanced diagnostic technology used in modern healthcare and laboratory testing.

Platform at a Glance

  • Modular biomarker-based architecture
  • Reusable assay foundation
  • Evidence-driven expansion
  • Independent evaluation per application
  • Applicability across human and animal health

Disclaimer

Platform applications beyond the initial focus are under evaluation and development. Scientific status and intended applications may vary by context.